Skip to Content
Merck

Potent inhibition of Norwalk virus by cyclic sulfamide derivatives.

Bioorganic & medicinal chemistry (2011-09-20)
Dengfeng Dou, Kok-Chuan Tiew, Guijia He, Sivakoteswara Rao Mandadapu, Sridhar Aravapalli, Kevin R Alliston, Yunjeong Kim, Kyeong-Ok Chang, William C Groutas
ABSTRACT

A new class of compounds that exhibit anti-norovirus activity in a cell-based system and embody in their structure a cyclosulfamide scaffold has been identified. The structure of the initial hit (compound 2a, ED(50) 4 μM, TD(50) 50 μM) has been prospected by exploiting multiple points of diversity and generating appropriate structure-activity relationships.

MATERIALS
Product Number
Brand
Product Description

Supelco
Sulfamic acid, analytical standard (for acidimetry), ACS reagent
Sigma-Aldrich
Sulfamic acid, 99.999% trace metals basis
Sigma-Aldrich
Sulfamic acid, reagent grade, 98%
Sigma-Aldrich
Sulfamic acid, ≥99.5% (alkalimetric)
Sigma-Aldrich
Sulfamic acid, ACS reagent, 99.3%
Sigma-Aldrich
Ammonium sulfamate, BioXtra, ≥98.0%
Sigma-Aldrich
Ammonium sulfamate, ACS reagent, ≥98.0%
Sigma-Aldrich
Sulfamic acid, ReagentPlus®, ≥99%